Serene has received authority to proceed with its first-in-human RSO Phase 1b trial in Canada, by Health Canada. The "No Objection Letter" from the Biologics and Genetic Therapies Directorate authorizes Serene to begin preparations for the trial with prospective clinical…
Two abstracts were submitted to the 10th International Conference on Isotopes on February 3-7, 2020, in Kuala Lampur. They are entitled, "“A new radioisotope-based treatment for veterinary and human arthritis” by Gilbert Gonzales, and “A Novel Sn-117m Colloid for Human…
An electronic publication entitled "Intraarticular injection of a tin-117m radiosynoviorthesis agent in normal canine elbows causes no adverse effects" by lead author Jimmy C Lattimer, DVM, appeared in Veterinary Radiol Ultrasound, 2019; Sep:60(5):567-574